StockData
Establishment Labs Holdings Inc. logo

Establishment Labs Holdings Inc. (ESTA) stock

ESTANasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 6/30
$69.51−0.31 (-0.44%)

Close on Nov 17, 2026Market cap $2.07BP/E –Yield –

Establishment Labs operating margin

Operating margin is operating income as a percentage of revenue.

Establishment Labs's operating margin for the twelve months ending Sep 30, 2026 was -6.6%. For fiscal 2025 it was -18.5%, against -30.1% the year before. The highest annual figure on record is -18.5% in fiscal 2025.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-18.5%+11.6
FY2024Dec 31, 2024-30.1%+9.3
FY2023Dec 31, 2023-39.4%−14.8
FY2022Dec 31, 2022-24.5%−4.7
FY2021Dec 31, 2021-19.8%+13.1
FY2020Dec 31, 2020-33.0%+1.6
FY2019Dec 31, 2019-34.5%+4.4
FY2018Dec 31, 2018-39.0%+18.6
FY2017Dec 31, 2017-57.6%–

Quarterly operating margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q3 FY2026Sep 30, 2026-3.6%+3.8
Q2 FY2026Jun 30, 2026-6.4%+21.1
Q1 FY2026Mar 31, 2026-10.9%+30.1
Q4 FY2025Dec 31, 2025-6.1%+35.9
Q3 FY2025Sep 30, 2025-7.5%+25.2
Q2 FY2025Jun 30, 2025-27.5%−6.3
Q1 FY2025Mar 31, 2025-41.0%−17.2
Q4 FY2024Dec 31, 2024-41.9%+28.1
Q3 FY2024Sep 30, 2024-32.7%+22.0
Q2 FY2024Jun 30, 2024-21.2%+7.1
Q1 FY2024Mar 31, 2024-23.8%−6.2
Q4 FY2023Dec 31, 2023-70.1%−40.0
Q3 FY2023Sep 30, 2023-54.6%−27.1
Q2 FY2023Jun 30, 2023-28.2%−3.0
Q1 FY2023Mar 31, 2023-17.5%−3.0
Q4 FY2022Dec 31, 2022-30.0%−3.5
Q3 FY2022Sep 30, 2022-27.5%+3.6
Q2 FY2022Jun 30, 2022-25.3%−10.8
Q1 FY2022Mar 31, 2022-14.5%−7.6
Q4 FY2021Dec 31, 2021-26.5%+3.2
Q3 FY2021Sep 30, 2021-31.1%−19.8
Q2 FY2021Jun 30, 2021-14.5%+77.2
Q1 FY2021Mar 31, 2021-6.9%+24.6
Q4 FY2020Dec 31, 2020-29.7%−11.6
Q3 FY2020Sep 30, 2020-11.4%+27.0
Q2 FY2020Jun 30, 2020-91.7%−48.4
Q1 FY2020Mar 31, 2020-31.5%+8.9
Q4 FY2019Dec 31, 2019-18.2%+34.4
Q3 FY2019Sep 30, 2019-38.4%−1.2
Q2 FY2019Jun 30, 2019-43.3%+2.8
Q1 FY2019Mar 31, 2019-40.4%−20.9
Q4 FY2018Dec 31, 2018-52.6%−13.7
Q3 FY2018Sep 30, 2018-37.1%+44.4
Q2 FY2018Jun 30, 2018-46.1%+17.5
Q1 FY2018Mar 31, 2018-19.4%–
Q4 FY2017Dec 31, 2017-38.8%–
Q3 FY2017Sep 30, 2017-81.5%–
Q2 FY2017Jun 30, 2017-63.5%–

More Establishment Labs figures

See a number that looks wrong?